Lisa M Nilsson

4PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 18, 2026
Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).

Axel Nelson, Rebecca Riise, Samuel Alsén

|Jun 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.

Vasu R Sah, Henrik Jespersen, Joakim Karlsson

|Jul 01, 2020
BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma.

Elisa Funck-Brentano, Dzeneta Vizlin-Hodzic, Jonas A Nilsson

|Jun 24, 2020
Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer cells.

Somsundar V Muralidharan, Lisa M Nilsson, Mattias F Lindberg

Pageof 1

Frequent Collaborators

4 joint publications

Jonas A Nilsson

2 joint publications

Roger Olofsson Bagge

1 joint publications

Somsundar V Muralidharan

1 joint publications

Mattias F Lindberg